Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression

The Brn-3a and Brn-3b transcription factor have opposite and antagonistic effects in neuroblastoma cells since Brn-3a is associated with differentiation whilst Brn-3b enhances proliferation in these cells. In this study, we demonstrate that like Brn-3a, Brn-3b physically interacts with p53. However, whereas Brn-3a repressed p53 mediated Bax expression but cooperated with p53 to increase p21cip1/waf1, this study demonstrated that co-expression of Brn-3b with p53 increases trans-activation of Bax promoter but not p21cip1/waf1. Consequently co-expression of Brn-3b with p53 resulted in enhanced apoptosis, which is in contrast to the increased survival and differentiation, when Brn-3a is co-expressed with p53. For Brn-3b to cooperate with p53 on the Bax promoter, it requires binding sites that flank p53 sites on this promoter. Furthermore, neurons from Brn-3b knock-out (KO) mice were resistant to apoptosis and this correlated with reduced Bax expression upon induction of p53 in neurons lacking Brn-3b compared with controls. Thus, the ability of Brn-3b to interact with p53 and modulate Bax expression may demonstrate an important mechanism that helps to determine the fate of cells when p53 is induced.

[1]  R. Oppenheim,et al.  Distinct susceptibility of developing neurons to death following Bax overexpression in the chicken embryo , 2006, Cell Death and Differentiation.

[2]  G. Brabant,et al.  The Brn‐3b POU family transcription factor represses plakoglobin gene expression in human breast cancer cells , 2006, International Journal of Cancer.

[3]  D. Latchman,et al.  Targeting Brn-3b in breast cancer therapy , 2006, Expert opinion on therapeutic targets.

[4]  A. Singer,et al.  Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a , 2006, Oncogene.

[5]  D. Chopin,et al.  [The p53 gene]. , 2005, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[6]  V. Budhram-Mahadeo,et al.  Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. , 2005, Cancer research.

[7]  D. Latchman,et al.  Coexpression of Brn‐3a POU protein with p53 in a population of neuronal progenitor cells is associated with differentiation and protection against apoptosis , 2004, Journal of neuroscience research.

[8]  V. Budhram-Mahadeo,et al.  The Brn-3b Transcription Factor Regulates the Growth, Behavior, and Invasiveness of Human Neuroblastoma Cells in Vitro and in Vivo* , 2004, Journal of Biological Chemistry.

[9]  R. Eisenman,et al.  Myc A Weapon of Mass Destruction , 2004, Cell.

[10]  J. Dennis,et al.  Activation of CDK4 Gene Expression in Human Breast Cancer Cells by the Brn-3b POU Family Transcription Factor , 2004, Cancer biology & therapy.

[11]  Y. Samuels,et al.  ASPP1 and ASPP2: Common Activators of p53 Family Members , 2004, Molecular and Cellular Biology.

[12]  D. Latchman,et al.  Sensory neurons from mice lacking the Brn-3b POU family transcription factor are resistant to death-inducing stimuli both in vitro and in vivo. , 2003, Brain research. Molecular brain research.

[13]  J. Lunec,et al.  The p53 pathway and its inactivation in neuroblastoma. , 2003, Cancer letters.

[14]  M. Oren,et al.  Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.

[15]  F. Rice,et al.  Erratum: Development of sensory neurons in the absence of NGF/TrkA signaling in vivo (Neuron (Febuary 2000) 25 (345-357)) , 2003 .

[16]  D. Latchman,et al.  The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells , 2002, Neuroscience Letters.

[17]  D. Latchman,et al.  Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter. , 2002, Nucleic acids research.

[18]  D. Latchman,et al.  The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21CIP1/Waf1 , 2002, Oncogene.

[19]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[20]  S. Benchimol.  p53-dependent pathways of apoptosis , 2001, Cell Death and Differentiation.

[21]  Xin Lu,et al.  ASPP proteins specifically stimulate the apoptotic function of p53. , 2001, Molecular cell.

[22]  D. Latchman,et al.  The Brn-3b POU family transcription factor regulates the cellular growth, proliferation, and anchorage dependence of MCF7 human breast cancer cells , 2001, Oncogene.

[23]  G. Stark,et al.  Regulation of the G2/M transition by p53 , 2001, Oncogene.

[24]  D. Latchman,et al.  The BRN-3A Transcription Factor Protects Sensory but Not Sympathetic Neurons from Programmed Cell Death/Apoptosis* , 2001, The Journal of Biological Chemistry.

[25]  T. Taniguchi,et al.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.

[26]  F. Rice,et al.  Development of Sensory Neurons in the Absence of NGF/TrkA Signaling In Vivo , 2000, Neuron.

[27]  W. Kaelin.  The p53 gene family , 1999, Oncogene.

[28]  B. Weber,et al.  The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells , 1999, Oncogene.

[29]  M V Chernov,et al.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.

[30]  W. Klein,et al.  POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification. , 1999, Developmental biology.

[31]  D. Latchman,et al.  p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription Factor* , 1999, The Journal of Biological Chemistry.

[32]  M. Lippman,et al.  BRCA1 and BRCA2 in breast cancer , 1999, Breast Cancer Research and Treatment.

[33]  D. Latchman,et al.  The Brn-3a transcription factor. , 1998, The international journal of biochemistry & cell biology.

[34]  M. Xiang,et al.  Requirement for Brn-3b in early differentiation of postmitotic retinal ganglion cell precursors. , 1998, Developmental biology.

[35]  S. Korsmeyer,et al.  Widespread Elimination of Naturally Occurring Neuronal Death inBax-Deficient Mice , 1998, The Journal of Neuroscience.

[36]  D. Latchman,et al.  POU Transcription Factors Brn-3a and Brn-3b Interact with the Estrogen Receptor and Differentially Regulate Transcriptional Activity via an Estrogen Response Element , 1998, Molecular and Cellular Biology.

[37]  A. Ashworth,et al.  Functions of the BRCA1 and BRCA2 genes. , 1998, Current opinion in genetics & development.

[38]  C. Isaacs,et al.  Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. , 1997, Patient education and counseling.

[39]  M. Schwartz,et al.  Coordinate Induction of the Three Neurofilament Genes by the Brn-3a Transcription Factor* , 1997, The Journal of Biological Chemistry.

[40]  Kevin A. Roth,et al.  bax Deficiency Prevents the Increased Cell Death of Immature Neurons in bcl-x-Deficient Mice , 1997, The Journal of Neuroscience.

[41]  D. Latchman,et al.  Inhibition of Neuronal Process Outgrowth and Neuronal Specific Gene Activation by the Brn-3b Transcription Factor* , 1997, The Journal of Biological Chemistry.

[42]  D. Latchman,et al.  The Brn-3a transcription factor induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins , 1997, Molecular and cellular biology.

[43]  D. Latchman,et al.  Differential regulation of genes encoding synaptic proteins by members of the Brn-3 subfamily of POU transcription factors. , 1996, Brain research. Molecular brain research.

[44]  P. Sawchenko,et al.  Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons , 1996, Nature.

[45]  J. Nathans,et al.  Targeted deletion of the mouse POU domain gene Brn-3a causes selective loss of neurons in the brainstem and trigeminal ganglion, uncoordinated limb movement, and impaired suckling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Latchman,et al.  The functionally antagonistic POU family transcription factors Brr‐3a and Brn‐3b show opposite changes in expression during the growth arrest and differentiation of human neuroblastoma cells , 1996, International journal of cancer.

[47]  S. Korsmeyer,et al.  BAX Is Required for Neuronal Death after Trophic Factor Deprivation and during Development , 1996, Neuron.

[48]  V. Rotter,et al.  p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells , 1996, Molecular and cellular biology.

[49]  Michael G. Rosenfeld,et al.  Role of transcription factors a Brn-3.1 and Brn-3.2 in auditory and visual system development , 1996, Nature.

[50]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[51]  J. Nathans,et al.  POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Möröy,et al.  Regulation of Neurite Outgrowth and SNAP-25 Gene Expression by the Brn-3a Transcription Factor (*) , 1995, The Journal of Biological Chemistry.

[53]  David L. Page,et al.  Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression , 1995, Nature Genetics.

[54]  T. Möröy,et al.  Activation of the α-Internexin Promoter by the Brn-3a Transcription Factor Is Dependent on the N-terminal Region of the Protein (*) , 1995, The Journal of Biological Chemistry.

[55]  D. Latchman,et al.  The levels of the antagonistic POU family transcription factors Brn-3a and Brn-3b in neuronal cells are regulated in opposite directions by serum growth factors , 1995, Neuroscience Letters.

[56]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[57]  H. Hermeking,et al.  Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.

[58]  D. Latchman,et al.  Cell cycle arrest and morphological differentiation can occur in the absence of apoptosis in a neuronal cell line , 1994, Neuroscience Letters.

[59]  A. Chumakov,et al.  Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription. , 1993, Oncogene.

[60]  D. Latchman,et al.  A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. , 1992, Nucleic acids research.

[61]  T. Hunter,et al.  Cyclins and cancer , 1991, Cell.

[62]  S. Bevan,et al.  Novel cell lines display properties of nociceptive sensory neurons , 1990, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[63]  W. El-Deiry,et al.  Regulation of p53 downstream genes. , 1998, Seminars in cancer biology.

[64]  T. Möröy,et al.  Chromosomal localization and sequences of the murine Brn-3 family of developmental control genes. , 1994, Cytogenetics and cell genetics.

[65]  R. Eeles,et al.  The role of TP53 in breast cancer development. , 1993, Cancer surveys.